Thus, the finding that PR was the only biomarker that predicted DCIS MIND xenograft invasive progression further validates our model as a tool for identifying biomarkers of aggressive DCIS and potential molecular underlying mechanisms of DCIS with invasive potential. This evidence concerns the gene PGR and ductal breast carcinoma in situ.